Santa Clara, CA — Centrify, a leading provider of Zero Trust Security through the power of Next-Gen Access, today announced medical technology pioneer QT Ultrasound has selected the Centrify Next-Gen Access platform to address multiple cybersecurity issues while helping the company further strengthen its compliance to HIPAA regulations.
Centrify enables QT Ultrasound to manage access to critical company information through privileged access management (PAM) policies and multi-factor authentication (MFA), and provide access to the company’s web-based applications via the platform’s single sign-on (SSO) capabilities.
Together, these features improve the company’s security posture and protect the identities and personal information of patients participating in medical trials.
“The potential risk associated with the unintended exposure of patient information isn’t limited to brand and reputation damage–there are also real costs associated with forensics, clean-up and the possibility of fines and lawsuits,” said Ron LoVetri, COO at QT Ultrasound.
Casey Smith, IT Manager at QT Ultrasound added, “We selected Centrify as the core technology behind our efforts to raise our security profile and protect the competitive advantages associated with our intellectual property, and at the same time help ensure compliance with HIPAA regulations–specifically the Personal Health Information (PHI) component. With Centrify, we can ensure that only approved users gain access to patient data.”
QT Ultrasound operates a mixed network environment consisting of Windows, MACs and Linux systems, all of which now leverage Centrify’s Application, Endpoint and Infrastructure services to achieve compliance and protect data.
Centrify has empowered the company to manage all administrative user accounts from a central location. And now, rather than acting as administrators of their own systems, users employ a simple, automated process of privilege elevation when necessary. This process ensures user activities remain aligned with the company’s predetermined security protocols.
“We evaluated several solutions and found Centrify to be the hands-down winner in terms of ease-of-use, cost-effectiveness and variety of endpoints managed,” said Smith, “Perhaps most important was Centrify’s ability to cover so many of our security needs with a single solution. Zero Trust Security allows us to simplify our entire approach to security, minimizing IT management and overhead requirements and streamlining our processes.”
Today, QT Ultrasound administrators log into systems with their own domain credentials, apply multi-factor authentication, and elevate privileges as needed. End users also have access to privilege elevation, which means endpoints remain secured at all times, but simple, everyday tasks like new app downloads are executed without increased reliance on IT support. The user experience will soon be further simplified with single sign-on access to web-based apps.
“We’re very pleased to set QT Ultrasound on the path towards Zero Trust Security by securing their applications, endpoints and infrastructure,” said Tom Kemp, CEO at Centrify. “Where multiple point solutions can increase costs and overhead while complicating things unnecessarily, we strive to provide a comprehensive solution for Zero Trust so organizations can remain laser-focused on their business initiatives–in this case, correctly identifying cancers within the body and ultimately, saving lives.”
For more information about Centrify Zero Trust Security visit www.centrify.com.
Centrify delivers Zero Trust Security through the power of Next-Gen Access. The Centrify Zero Trust Security model assumes that users inside a network are no more trustworthy than those outside the network. Centrify verifies every user, validates their devices, and limits access and privilege. Centrify also utilizes machine learning to discover risky user behavior and apply conditional access — without impacting user experience. Centrify’s Next-Gen Access is the only industry-recognized solution that uniquely converges Identity-as-a-Service (IDaaS), enterprise mobility management (EMM) and privileged access management (PAM). Over 5,000 worldwide organizations, including over half the Fortune 100, trust Centrify to proactively secure their businesses.
About QT Ultrasound
QT Ultrasound is a privately held company engaged in the research, development, and commercialization of Transmission Ultrasound technology. Their research has been supported by over $15 million in funding from the National Cancer Institute of the US National Institutes of Health. The company’s clinical trials have been conducted at many prestigious institutions in the US and Europe and it is currently enrolling women in several studies at the Marin Breast Health Trial Center in Novato, California.
For more information about QT Ultrasound visit www.qtultrasound.com.
Centrify is a registered trademark of Centrify Corporation in the United States and other countries. All other trademarks are the property of their respective owners.